Prosecution Insights
Last updated: August 17, 2026
Application No. 19/444,133

TISSUE ABLATION CATHETER WITH AN INSULATOR BETWEEN INNER AND OUTER ELECTRODES

Final Rejection §103
Filed
Jan 08, 2026
Priority
Dec 09, 2022 — continuation of 11/690,671 +2 more
Examiner
OUYANG, BO
Art Unit
3794
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Field Medical Inc.
OA Round
2 (Final)
61%
Grant Probability
Moderate
3-4
OA Rounds
3y 5m
Est. Remaining
70%
With Interview

Examiner Intelligence

Grants 61% of resolved cases
61%
Career Allowance Rate
243 granted / 400 resolved
-9.2% vs TC avg
Moderate +9% lift
Without
With
+8.9%
Interview Lift
resolved cases with interview
Typical timeline
4y 0m
Avg Prosecution
41 currently pending
Career history
452
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
58.5%
+18.5% vs TC avg
§102
21.2%
-18.8% vs TC avg
§112
16.3%
-23.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 400 resolved cases

Office Action

§103
DETAILED ACTION Applicant's amendments and remarks, filed 7/1/26, are fully acknowledged by the Examiner. Currently, claims 1-22 and 26-28 are pending with claims 23-25 canceled, claims 1 and 26 amended. The following is a complete response to the 7/1/26 communication. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-17, 19-22, and 26-28 is/are rejected under 35 U.S.C. 103 as being unpatentable over Weinstein (US 6,102,046) in view of Greeley (US 2023/0039545), in view of Mickelson (US 2015/0182740). Regarding claim 1, Weinstein teaches a method for tissue ablation comprising: advancing an ablation catheter to a target tissue (Fig. 15), the ablation catheter comprising a tubular body having an inner surface (tubular body 276 with inner surface facing inward and defining 282 as in Fig. 15), an outer surface (outer surface of 276 facing 274), and a distal end (distal end facing 286), one or more inner electrodes disposed on the inner surface (inner electrode 270), and one or more outer electrodes disposed on the outer surface (outer electrode 272); generating a first electric field having a first vector direction using a first voltage pattern for the one or more inner electrodes and the one or more outer electrodes (creating a first voltage pattern defined by 278). Weinstein is silent regarding generating a second, different electric field having a second, different vector direction by switching the first voltage pattern for the one or more inner electrodes and the one or more outer electrodes to a second, different voltage pattern. However, Greeley teaches a tubular multielectrode treatment device using bipolar and monopolar electrode selections to result in different treatment modalities (par. [0002], par. [0026]). It would have been obvious to one of ordinary skill in the art to modify Weinstein with the modalities of Greeley, to allow for different treatment modalities on tissue (par. [0002]).Weinstein is not explicit regarding treating a cardia arrhythmia and ablating the target tissue comprises electroporation of the target tissue with the first and second electric fields.However, Mickelson teaches ablation for treating arrhythmia (par. [0148]), and treating a cardiac arrhythmia by ablating the target tissue comprises electroporation of the target tissue (par. [0160], unipolar or bipolar as in par. [0190]). It would have been obvious to one of ordinary skill in the art to use the device of Weinstein to treat arrhythmia, to allow for a method of treating cardiac tissue. It would have been obvious to one of ordinary skill in the art at the time of invention to use the device of Weinstein for electroporation as an electrosurgical function that RF ablation catheters can deliver, allowing for treatment with reduced thermal transfer. Regarding claim 2, Weinstein teaches bipolar treatment in the first pattern with wherein in the first voltage pattern (col. 28, lines 6-19), the one or more inner electrodes have a first polarity (270 as active electrode of bipolar device), and the one or more outer electrodes have a second polarity (272 as return electrode of bipolar device). Regarding claim 3, Weinstein is silent wherein in the second voltage pattern, voltage is applied solely to the one or more outer electrodes. However, Greeley teaches a tubular multielectrode treatment device using bipolar and monopolar electrode selections to result in different treatment modalities (par. [0026] with monopolar for cutting, par. [0027] voltage to outer electrode 12). It would have been obvious to one of ordinary skill in the art to modify Weinstein with the monopolar modality of Greeley, to allow for different treatment modalities on tissue (par. [0002]). Regarding claim 4, Weinstein teaches that the probe may include an array of electrode terminals rather than the annular electrode (col. 20 lines 52-67), but is not explicit wherein an outer electrode of the one or more outer electrodes has a first polarity, and another one of the one or more outer electrodes has a second polarity. However, Greeley teaches switches to determine the polarity and other properties of given electrodes (par. [0149]). It would have been obvious to one of ordinary skill in the art to modify Weinstein with the switching of the electrodes of Greeley, to allow for different treatment modalities on tissue (par. [0002]). Regarding claim 5, Weinstein does not necessitate wherein the one or more outer electrodes comprises two outer electrodes, and wherein in the first voltage pattern, each of the two outer electrodes have a same polarity. However, Weinstein teaches that the probe may include an array of electrode terminals rather than the annular electrode (col. 20 lines 52-67). It would have been obvious to one of ordinary skill in the art to modify Weinstein such that the annular electrode is an array of electrodes, as a known alternative that is capable of treating tissue. Regarding claim 6, Weinstein is not explicit wherein the one or more outer electrodes comprises two outer electrodes, and wherein in the second voltage pattern, the two outer electrodes have different polarities. However, Weinstein teaches that the probe may include an array of electrode terminals rather than the annular electrode (col. 20 lines 52-67). It would have been obvious to one of ordinary skill in the art to modify Weinstein such that the annular electrode is an array of electrodes, as a known alternative that is capable of treating tissue. Regarding claim 7, Weinstein teaches wherein in the first voltage pattern, at least one inner electrode of the one or more inner electrodes has a first polarity (bipolar treatment), but is not explicit regarding in the second voltage pattern, a voltage is not applied to the at least one inner electrode. However, Greeley teaches a tubular multielectrode treatment device using bipolar and monopolar electrode selections to result in different treatment modalities (par. [0002], par. [0026]). It would have been obvious to one of ordinary skill in the art to modify Weinstein with the modalities of Greeley, to allow for different treatment modalities on tissue (par. [0002]). Regarding claim 8, Weinstein teaches wherein the first polarity is positive (active electrode 270). Regarding claim 9, Weinstein is not explicit wherein in the first voltage pattern, a voltage is not applied to at least one electrode of the one or more outer electrodes and in the second voltage pattern the at least one electrode has a first polarity. However, Greeley teaches a tubular multielectrode treatment device using bipolar and monopolar electrode selections to result in different treatment modalities (par. [0002], par. [0026]). It would have been obvious to one of ordinary skill in the art to modify Weinstein with the modalities of Greeley, to allow for different treatment modalities on tissue (par. [0002]). Regarding claim 10, Weinstein teaches wherein each of the one or more outer electrodes are offset from the distal end of the tubular body along a longitudinal axis of thereof (electrode 272 offset from distal end of 276). Regarding claim 11, Weinstein teaches wherein each of the one or more inner electrodes are offset from the distal end of the tubular body along a longitudinal axis of thereof (inner electrodes 270 offset from the distal end of 280). Regarding claim 12, Weinstein is not explicit wherein switching from the first voltage pattern to the second voltage pattern occurs without repositioning the ablation catheter. However, Greeley teaches switching bipolar and monopolar without repositioning (par. [0037]). It would have been obvious to one of ordinary skill in the art to modify Weinstein with the modalities of Greeley, to allow for different treatment modalities on tissue (par. [0002]). Regarding claim 13, Weinstein is not explicit regarding further comprising switching from the second voltage pattern to a third voltage pattern to generate a third electric field different from the second electric field, the third electric field having a third vector direction. However, Greeley teaches a tubular multielectrode treatment device using bipolar and monopolar electrode selections to result in different treatment modalities (par. [0038], monopolar and bipolar, but also a bipolar between different electrodes to reduce size and volume of tissue). It would have been obvious to one of ordinary skill in the art to modify Weinstein with a third voltage pattern with a third vector direction, as in Greeley, as a way to produce multiple treatment modalities for different treatment cases. Regarding claim 14, Weinstein is not explicit wherein in the first voltage pattern, a voltage is not applied to an outer electrode of the one or more outer electrodes, in the second voltage pattern the outer electrode has a first polarity, and in the third voltage pattern, the outer electrode has the first polarity. However, Greeley teaches a tubular multielectrode treatment device using bipolar and monopolar electrode selections to result in different treatment modalities (par. [0038], monopolar and bipolar, but also a bipolar between different electrodes to reduce size and volume of tissue). It would have been obvious to one of ordinary skill in the art to modify Weinstein with different voltage activations of different electrodes, as in Greeley, as a way to produce multiple treatment modalities for different treatment cases. Regarding claim 15, Weinstein teaches wherein the first polarity is negative (270 as return electrode). Regarding claim 16, Weinstein is not explicit regarding repeatedly switching between one or more of the first, second, or third voltage patterns. However, Greeley teaches switching between different voltage patterns (par. [0037]).It would have been obvious to one of ordinary skill in the art to modify Weinstein with different voltage activations of different electrodes, as in Greeley, as a way to produce multiple treatment modalities for different treatment cases. Regarding claim 17, Weinstein is not explicit wherein an angular difference between the first vector direction and the second vector direction is between about 1° to about 90°. However, one of ordinary skill in the art would appreciate that in the combination, depending on vectors of the average electric field vector of the first treatment and second treatment, the difference may be at least one degree. Regarding claim 19, Weinstein teaches wherein the tubular body comprises an electrically insulating material (insulator 276). Regarding claim 20, Weinstein teaches wherein the one or more inner electrodes and the one or more outer electrodes are separated by the electrically insulating material (insulator 276 separates 270 from 272). Regarding claim 21, Weinstein teaches wherein a current path between the one or more inner electrodes and the one or more outer electrodes bends around the distal end of the tubular body (Fig. 15 with current path 278 bending around the distal end of the tubular body). Regarding claim 22, Weinstein is not explicit regarding the second voltage pattern, but teaches wherein setting the first voltage pattern and switching current is accomplished by a controller electrically coupled to the one or more inner electrodes and the one or more outer electrodes (col. 11, line 61 to col. 12 line 9). It would have been obvious to one of ordinary skill in the art that switching to the second pattern would be controlled by a controller as in Weinstein as a device that controls voltage and treatment elements of the device. Regarding claim 26, Weinstein is silent wherein the cardiac arrhythmia comprises atrial fibrillation. However, Mickelson teaches ablation for treating arrhythmia (par. [0148], specifically atrial fibrillation as in par. [0003]). It would have been obvious to one of ordinary skill in the art to use the device of Weinstein to treat arrhythmia, to allow for a method of treating cardiac tissue. Regarding claim 27, Weinstein teaches wherein one or more of the first electric field or the second electric field has a symmetrical contour around the distal end of the tubular body (Fig. 15). Regarding claim 28, Weinstein teaches wherein the ablation catheter is advanced intravascularly (at least col. 7, lines 3-4). Claim(s) 18 is/are rejected under 35 U.S.C. 103 as being unpatentable over Weinstein (US 6,102,046) in view of Greeley, in view of Mickelson, in further view of Cosman (US 2017/0049513). Regarding claim 18, Weinstein is not explicit wherein switching between the first voltage pattern and the second voltage pattern occurs during a time period ranging from about 10 nanoseconds to about 1 second. However, Cosman teaches switching modalities in different time periods, such as 1 millisecond (par. [0111]). It would have been obvious to one of ordinary skill in the art to modify Weinstein with the switching time of Cosman, as known times for switching between treatments to occur. Response to Arguments Applicant's arguments filed 7/1/26 have been fully considered but they are not persuasive. Applicant argues that one of ordinary skill in the art would not modify Weinstein with the electroporation of Mickelsen, asserting that the mechanism of Weinstein uses a different modality to ablate tissue. However, Weinstein teaches the desire for different types of treatment, not just plasma (col. 7, lines 10-19 cutting, coagulating, ablation). Mickelsen teaches using a generator 700 to allow the device to deliver multiple treatment methods (par. [0130]). It would have been obvious to one of ordinary skill in the art to look to Mickelsen in the myriad ways of delivering energy to an electrode device to ablate or treat tissue, including using electroporation to ablate tissue (par. [0138]). Applicant further argues that one of ordinary skill in the art would not look to Greeley for generating different voltage activations for electroporation to treat cardia arrhythmia. However, given that Mickelsen teaches unipolar and bipolar configurations for electroporation (par. [0159], [0190]), one of ordinary skill in the art would look to Greeley to be able to switch treatment patterns to deliver electroporation in a pattern desired by the user. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to BO OUYANG whose telephone number is (571)272-8831. The examiner can normally be reached M-F 8-5 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joanne Rodden can be reached at 303-297-4276. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BO OUYANG/Examiner, Art Unit 3794 /MICHAEL F PEFFLEY/Primary Examiner, Art Unit 3794
Read full office action

Prosecution Timeline

Jan 08, 2026
Application Filed
Apr 01, 2026
Non-Final Rejection mailed — §103
Jul 01, 2026
Response Filed
Jul 30, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12702478
DEVICES, METHODS, AND COMPOSITIONS FOR THERMAL ACCELERATION AND DRUG DELIVERY
4y 2m to grant Granted Aug 11, 2026
Patent 12697167
APPARATUS AND METHODS FOR MINIMALLY INVASIVE DISSECTION AND MODIFICATION OF TISSUES
5y 0m to grant Granted Aug 04, 2026
Patent 12667410
ELECTROSURGICAL DEVICE
4y 4m to grant Granted Jun 30, 2026
Patent 12653607
INTRAVASCULAR CATHETER TIP ELECTRODE ASSEMBLIES
5y 5m to grant Granted Jun 16, 2026
Patent 12653604
DEVICE AND METHOD FOR FRACTIONAL RF TREATMENT OF THE SKIN
4y 6m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
61%
Grant Probability
70%
With Interview (+8.9%)
4y 0m (~3y 5m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 400 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month